Targeted thrombolysis strategies for neuroprotective effect

Stroke is usually treated by systemic thrombolytic therapy if the patient presents within an appropriate time window. There is also widespread interest in the development of thrombolytic agents that can be used in cases of delayed presentation. Current agents that can be used in cases of delayed pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Junping, Ma, Guoxing, Lv, Zhimin, Zhou, Yu, Wen, Chunguang, Wu, Yaqing, Xu, Ruian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Academic Discussion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160859/
https://www.ncbi.nlm.nih.gov/pubmed/25221585
http://dx.doi.org/10.4103/1673-5374.137580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160859/
https://www.ncbi.nlm.nih.gov/pubmed/25221585
http://dx.doi.org/10.4103/1673-5374.137580

Ejemplares similares